FDA Approves AbbVie Oral Pill for Parkinson's Disease
AbbVie received FDA approval for an oral pill to treat Parkinson's disease, creating a new national option. The company has not yet shared details on pricing, launch timing, or clinical differentiation. As a result, real-world impact and patient adoption remain pending.
Why it matters
Parkinson's disease needs more treatment options, and a newly approved pill adds another therapy for patients.
CHECKED · 1 SOURCE · UNCORROBORATED
← All news